These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32363665)

  • 1. Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation.
    Pérez A; Montoro J; Hernani R; Lorenzo I; Hernández-Boluda JC; Giménez E; Gómez MD; Balaguer-Roselló A; Gonzalez-Barberá E; Guerreiro M; Aguilar C; Navarro D; Solano C; Sanz J; Piñana JL
    Transpl Infect Dis; 2020 Aug; 22(4):e13301. PubMed ID: 32363665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.
    Piñana JL; Gómez MD; Montoro J; Lorenzo I; Pérez A; Giménez E; González-Barberá EM; Carretero C; Guerreiro M; Salavert M; Sanz G; Hernández-Boluda JC; Borrás R; Sanz J; Solano C; Navarro D
    Transpl Infect Dis; 2019 Oct; 21(5):e13158. PubMed ID: 31402532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.
    Wang L; Allen J; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Lim F; Oon L; Tan TT; Linn YC; Tan BH
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28295964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.
    Piñana JL; Gómez MD; Pérez A; Madrid S; Balaguer-Roselló A; Giménez E; Montoro J; González EM; Vinuesa V; Moles P; Hernández-Boluda JC; Salavert M; Calabuig M; Sanz G; Solano C; Sanz J; Navarro D
    Transpl Infect Dis; 2018 Aug; 20(4):e12926. PubMed ID: 29809298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
    Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
    Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease.
    Pérez A; Gómez D; Montoro J; Chorão P; Hernani R; Guerreiro M; Villalba M; Albert E; Carbonell-Asins JA; Hernández-Boluda JC; Navarro D; Solano C; Piñana JL
    Bone Marrow Transplant; 2024 Aug; 59(8):1118-1126. PubMed ID: 38730040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
    Piñana JL; Xhaard A; Tridello G; Passweg J; Kozijn A; Polverelli N; Heras I; Perez A; Sanz J; Berghuis D; Vázquez L; Suárez-Lledó M; Itäla-Remes M; Ozcelik T; Iturrate Basarán I; Karakukcu M; Al Zahrani M; Choi G; Cuesta Casas MA; Batlle Massana M; Viviana A; Blijlevens N; Ganser A; Kuskonmaz B; Labussière-Wallet H; Shaw PJ; Yegin ZA; González-Vicent M; Rocha V; Ferster A; Knelange N; Navarro D; Mikulska M; de la Camara R; Styczynski J
    J Infect Dis; 2021 May; 223(9):1564-1575. PubMed ID: 32860509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.
    Piñana J; Montoro J; Aznar C; Lorenzo I; Gómez MD; Guerreiro M; Carretero C; González-Barberá EM; Balaguer-Roselló A; Sanz R; Salavert M; Navarro D; Sanz MA; Sanz G; Sanz J
    J Infect; 2020 Mar; 80(3):333-341. PubMed ID: 31972212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
    Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
    Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients.
    Jacobs SE; Soave R; Shore TB; Satlin MJ; Schuetz AN; Magro C; Jenkins SG; Walsh TJ
    Transpl Infect Dis; 2013 Oct; 15(5):474-86. PubMed ID: 23890179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality.
    Seo S; Waghmare A; Scott EM; Xie H; Kuypers JM; Hackman RC; Campbell AP; Choi SM; Leisenring WM; Jerome KR; Englund JA; Boeckh M
    Haematologica; 2017 Jun; 102(6):1120-1130. PubMed ID: 28183847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study.
    Piñana JL; Pérez A; Montoro J; Giménez E; Gómez MD; Lorenzo I; Madrid S; González EM; Vinuesa V; Hernández-Boluda JC; Salavert M; Sanz G; Solano C; Sanz J; Navarro D
    Clin Infect Dis; 2019 May; 68(11):1894-1903. PubMed ID: 30239624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
    Piñana JL; Tridello G; Xhaard A; Wendel L; Montoro J; Vazquez L; Heras I; Ljungman P; Mikulska M; Salmenniemi U; Perez A; Kröger N; Cornelissen J; Sala E; Martino R; Geurten C; Byrne J; Maertens J; Kerre T; Martin M; Pascual MJ; Yeshurun M; Finke J; Groll AH; Shaw PJ; Blijlevens N; Arcese W; Ganser A; Suarez-Lledo M; Alzahrani M; Choi G; Forcade E; Paviglianiti A; Solano C; Wachowiak J; Zuckerman T; Bader P; Clausen J; Mayer J; Schroyens W; Metafuni E; Knelange N; Averbuch D; de la Camara R
    J Infect Dis; 2024 Jan; 229(1):83-94. PubMed ID: 37440459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey.
    Piñana JL; Pérez A; Montoro J; Hernani R; Lorenzo I; Giménez E; Gómez MD; Guerreiro M; González-Barberá EM; Carretero C; Salavert M; Balaguer-Roselló A; Sanz G; Hernández-Boluda JC; Solano C; Sanz J; Navarro D
    Bone Marrow Transplant; 2020 Feb; 55(2):431-440. PubMed ID: 31551521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.
    Shah DP; Ghantoji SS; Ariza-Heredia EJ; Shah JN; El Taoum KK; Shah PK; Nesher L; Hosing C; Rondon G; Champlin RE; Chemaly RF
    Blood; 2014 May; 123(21):3263-8. PubMed ID: 24700783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhinovirus Infections among Hematopoietic Stem Cell Transplant Recipients: A Pre-Transplant Dilemma?
    Barral S; Mamin A; Dantin C; Masouridi-Levrat S; Chalandon Y; Kaiser L; Vu DL
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ogimi C; Krantz EM; Golob JL; Waghmare A; Liu C; Leisenring WM; Woodard CR; Marquis S; Kuypers JM; Jerome KR; Pergam SA; Fredricks DN; Sorror ML; Englund JA; Boeckh M
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2293-2301. PubMed ID: 29777867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy.
    Pérez A; Montoro J; Chorão P; Gómez D; Guerreiro M; Giménez E; Villalba M; Sanz J; Hernani R; Hernández-Boluda JC; Lorenzo I; Navarro D; Solano C; Ljungman P; Piñana JL
    Infection; 2024 Apr; ():. PubMed ID: 38653955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of community-acquired respiratory viruses in allogeneic stem-cell transplant recipients and controls-A prospective cohort study.
    Rachow T; Lamik T; Kalkreuth J; Kurze S; Wagner K; Stier P; Hammersen FJ; Rüthrich MM; Winkelmann N; Klink A; Hilgendorf I; Hermann B; Lang S; Hochhaus A; von Lilienfeld-Toal M
    Transpl Infect Dis; 2020 Dec; 22(6):e13415. PubMed ID: 32779843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection.
    Shiraiwa S; Harada K; Onizuka M; Kawakami S; Hara R; Aoyama Y; Amaki J; Ogiya D; Suzuki R; Toyosaki M; Machida S; Omachi K; Kawada H; Ogawa Y; Ando K
    J Infect Chemother; 2022 Sep; 28(9):1279-1285. PubMed ID: 35691863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.